Humex Adultes Expectorant Sans Sucre Édulcorée À La Saccharine Sodique (Carbocisteine)

Humex Adultes Expectorant is indicated for situations where mucus becomes thick and difficult to clear from the airways. The mucolytic action helps to thin secretions, facilitating expectoration.

• Relief of productive cough associated with acute respiratory infections.
• Management of chronic bronchitis with persistent sputum production.
• Adjunct therapy for COPD exacerbations featuring viscous secretions.
• Support during seasonal upper‑respiratory tract infections with chest congestion.
• Use in patients who require a sugar‑free formulation for cough management.

• Carbocisteine acts as a mucolytic by cleaving disulfide bonds within mucoproteins, which reduces the molecular weight and viscosity of mucus. The resulting thinner secretions are more easily transported by ciliary activity and cough, improving clearance from the bronchial tree. The drug does not possess direct bronchodilator or anti‑inflammatory properties, and its effect is limited to modifying mucus characteristics. Overall, the pharmacodynamic profile supports its use as an expectorant.

Carbocisteine is generally well tolerated, but a range of mild to moderate adverse events have been reported in clinical use, and rare serious reactions may occur.

Common

• Nausea or mild gastrointestinal discomfort.
• Taste alteration or mild bitterness in the mouth.
• Mild headache or dizziness.
• Transient abdominal cramps.
• Mild dry mouth.
• Transient metallic taste.

Serious

• Allergic skin reactions such as rash or urticaria.
• Severe gastrointestinal upset with vomiting or diarrhea.
• Anaphylactic reaction (rare).

When using Humex Adultes Expectorant, certain precautions should be observed to ensure safe and effective use.

• Verify that the product is appropriate for adult patients only; it is not formulated for children.
• Consult a healthcare professional before use if you have chronic respiratory diseases such as asthma or COPD.
• Avoid use in individuals with known hypersensitivity to carbocisteine or saccharin.
• Use with caution in patients with renal impairment, as the drug is eliminated renally.
• Discontinue the product and seek medical advice if symptoms persist beyond a few days or worsen.
• Pregnant or breastfeeding women should discuss potential risks with a clinician, as safety data are limited.

Carbocisteine may interact with other medicines or substances, and certain combinations should be avoided or monitored.

Avoid

• Concomitant use with strong oxidizing agents that could degrade carbocisteine in solution.
• Simultaneous administration of other mucolytic agents without medical supervision.

Use with caution

• Antitussive (cough‑suppressing) medications, as they may counteract the expectorant effect.
• Bronchodilators, because combined therapy may alter cough reflex sensitivity.
• Drugs that affect renal function (e.g., NSAIDs, aminoglycosides), which could modify carbocisteine clearance.
• Alcohol, which may increase gastrointestinal irritation.